CCL2 and breast cancer: The levels of VEGF, G-CSF, GM-CSF, CCL5, and MCP-1 were increased, while the levels of IL-6, IL-1β and TNFα were decreased in BC patients with T2-T4 stage, compared to BC patients with Ta-T1 stage, and healthy controls (Figure 4).